BioCryst Pharmaceuticals Aktie
6,41
EUR
+0,02
EUR
+0,34
%
7,63
USD
-0,06
USD
-0,78
%
Werbung
BioCryst Pharmaceuticals Aktie Analyse
| 02.01.18 | BioCryst Pharmaceuticals Outperform | RBC Capital Markets | |
| 21.04.15 | BioCryst Pharmaceuticals Outperform | FBR Capital | |
| 02.12.09 | BioCryst Pharmaceuticals market outperform | JMP Securities LLC | |
| 14.10.09 | BioCryst Pharmaceuticals market outperform | JMP Securities LLC | |
| 13.08.07 | BioCryst Pharmaceuticals above average | Caris & Company, Inc. | |
| 26.06.07 | BioCryst Pharmaceuticals above average | Caris & Company | |
| 13.02.07 | BioCryst Pharmaceuticals | Biotech-Report | |
| 26.06.06 | BioCryst Pharmaceuticals stark kaufen | Jaindl & Mautz | |
|
Werbung
|
|||
| 14.06.06 | BioCryst Pharmaceuticals Above Average | Caris & Company | |
| 10.03.06 | BioCryst Pharmaceuticals buy | CE Unterberg, Towbin | |
| 20.02.06 | BioCryst Pharmaceuticals buy | CE Unterberg, Towbin | |
| 11.08.05 | BioCryst Pharmaceuticals Buy | Wedbush Morgan | |
Werbung
Werbung